• Most Popular
  • Most Shared

REUTERS SHOWCASE

New Antibiotics

New Antibiotics

U.S. government taps GlaxoSmithKline for new antibiotics  Full Article 

Medical Marijuana

Medical Marijuana

Los Angeles voters OK move to curtail medical marijuana outlets  Full Article 

Birdflu Cost

Birdflu Cost

China's bird flu outbreak cost $6.5 billion  Full Article 

Group Workouts

Group Workouts

Putting group fitness classes in the proper light  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage 

MedImmune says swine flu vaccine ready end-Sept

Related Topics

Stocks

   

WASHINGTON | Fri Sep 11, 2009 12:18am IST

WASHINGTON (Reuters) - MedImmune's inhaled vaccine against the pandemic H1N1 virus could be ready to start shipping to the U.S. government by the end of September, a company official said on Thursday.

MedImmune's Dr. Raburn Mallory said the company, a unit of AstraZeneca, has submitted safety data for their nasal spray swine flu vaccine to the U.S. Food and Drug Administration.

"There are no red flags there. We think we can have 5 million doses ready to distribute at the end of September," Mallory said in an interview. U.S. officials had not expected vaccination to begin until mid-October.

(Editing by Sandra Maler)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.